Jacques Raphael
Impact in
Papers in
- Oncology 44
- HER2/EGFR in Cancer Research 11
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 11
- Cancer Treatment and Pharmacology 8
-
- Lung Cancer Treatments and Mutations 14
- Advanced Breast Cancer Therapies 7
- Co-authors
- Rania Chehade (3 shared papers)Phillip Blanchette (23 shared papers)Gabriel Boldt (13 shared papers)Ricardo Fernandes (7 shared papers)Richard AC Hughes (1 shared paper)A V Swan (1 shared paper)P.A. van Doorn (1 shared paper)Saman Maleki Vareki (2 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Breast Cancer Research and Treatment (4 papers)Lung Cancer (3 papers)European Journal of Cancer (2 papers)Cancers (2 papers)
- Partner nations
- CanadaUnited KingdomFrance
In The Last Decade
Jacques Raphael
63 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Oncology 541
- Neurology 182
- Cancer Research 167
- Pulmonary and Respiratory Medicine 315
- Family Practice 18
Countries citing papers authored by Jacques Raphael
This map shows the geographic impact of Jacques Raphael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Raphael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Raphael more than expected).
Fields of papers citing papers by Jacques Raphael
This network shows the impact of papers produced by Jacques Raphael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Raphael. The network helps show where Jacques Raphael may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques Raphael, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 264 | |
| 2 | Intravenous immunoglobulin for Guillain-Barre syndrome.[update in Cochrane Database Syst Rev. 2004;(1):CD002063; PMID: 14973982] | 2001 | 160 |
| 3 | 2019 | 112 | |
| 4 | 2015 | 41 | |
| 5 | [The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases]. | 1986 | 36 |
| 6 | 2017 | 30 | |
| 7 | 2020 | 24 | |
| 8 | 2019 | 23 | |
| 9 | 2019 | 21 | |
| 10 | 2018 | 19 | |
| 11 | 2020 | 18 | |
| 12 | 2017 | 18 | |
| 13 | 2016 | 18 | |
| 14 | 2015 | 15 | |
| 15 | 2019 | 14 | |
| 16 | 2021 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2020 | 11 | |
| 19 | 2017 | 11 | |
| 20 | 2020 | 11 |
About Jacques Raphael
Jacques Raphael is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Genetics, having authored 70 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (11 papers), Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Genomics and Diagnostics (7 papers) and Advanced Breast Cancer Therapies (7 papers). The work is most often cited by research in Oncology (541 citations), Neurology (182 citations), Cancer Research (167 citations), Pulmonary and Respiratory Medicine (315 citations) and Family Practice (18 citations). Jacques Raphael has collaborated with scholars based in Canada, United Kingdom and France. Frequent co-authors include Rania Chehade, Phillip Blanchette, Gabriel Boldt, Ricardo Fernandes, Richard AC Hughes, A V Swan, P.A. van Doorn, Saman Maleki Vareki, S. M. Qasim Hussaini and Daniel Breadner. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Lung Cancer, European Journal of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.